Global Health Technology Coalition’s “Breakthroughs”: The state of reproductive health R&D for developing countries
“…Dale Halliday — an analyst at Policy Cures — discusses the finding of Policy Cures’ report on funding for reproductive health technology research and development (R&D) in developing countries” and notes that “[c]onsidering the health burden, capacity for health improvements, and potential impact on broader poverty indicators, as well as the size of the reproductive health R&D sector as a whole, investment in R&D for reproductive health products in developing countries is small” (2/4).